Brian Shapiro, in Orofino, ID - Marriage & Family Therapist

Brian Shapiro, is a Marriage & Family Therapist based in Orofino, Idaho. Brian Shapiro is licensed to practice in Idaho (license number LMFT-32) and his current practice location is 155 Main Street Stuite C, Orofino, Idaho. He can be reached at his office (for appointments etc.) via phone at (208) 476-4230.

NPI number for Brian Shapiro is 1295130698 and his current mailing address is 212 N 1st Ave Ste 103, Sandpoint, Idaho. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1295130698.

Contact Information

	Brian Shapiro,
	155 Main Street Stuite C, Orofino, ID 83544
	(208) 476-4230
	Not Available

Healthcare Provider's Profile

Full Name	Brian Shapiro
Gender	Male
Speciality	Marriage & Family Therapist
Location	155 Main Street Stuite C, Orofino, Idaho
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1295130698
Provider Enumeration Date: 10/28/2014
Last Update Date: 10/28/2014

Medical Identifiers

Medical identifiers for Brian Shapiro such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1295130698	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
106H00000X	Marriage & Family Therapist	LMFT-32 (Idaho)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Brian Shapiro is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Brian Shapiro, 212 N 1st Ave Ste 103, Sandpoint, ID 83864-1400 Ph: (208) 265-8195	Brian Shapiro, 155 Main Street Stuite C, Orofino, ID 83544 Ph: (208) 476-4230

News Archive

FDA approves first adjuvant treatment for patients with non-small cell lung cancer

Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation.

Researchers report one-third cut in the rate of lethal SSIs after colorectal operations

A patient safety team including researchers in the Johns Hopkins Armstrong Institute for Patient Safety and Quality reported a one-third cut in the rate of costly and potentially lethal surgical site infections (SSIs) following colorectal operations after requiring use of a simple safety checklist and urging caregivers to speak up if they see potentially unsafe practices.

Study demonstrates preventive effect of urate lowering therapy on cardiovascular mortality

The use of urate lowering therapy might successfully prevent death from cardiovascular disease in people with gout, according to research presented at the Nov 2010, American College of Rheumatology Annual Scientific Meeting in Atlanta.

Patients and healthcare professionals willing to trade false-positive diagnoses, study finds

Both patients and healthcare professionals believe diagnosis of extracolonic malignancy with screening computed tomography (CT) colonography greatly outweighs the potential disadvantages of subsequent radiologic or invasive follow-up tests precipitated by false-positive diagnoses, according to a new study published in the October issue of the journal Radiology.

Children born to mothers with rheumatoid arthritis may have increased risk of developing epilepsy

A new study shows a link between mothers with rheumatoid arthritis and children with epilepsy.

Brian Shapiro, - Couples Therapy in Orofino, ID